Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mentor Capital Ltd Nath Bio-Genes (India) Ltd - 537291 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Nath Bio-Genes (India) Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Nath Bio-Genes (India) Ltd - 537291 - Shareholder Meeting / Postal Ballot-Outcome of AGM
1.Proceedings of Agm held on 10th August 2019 2.Voting Results 3. Scrutinizers Report Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Conference Call with Investor held on 06th August 2019 Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation on unaudited financial results Nath Bio-Genes (India) Ltd - 537291 - Standalone Unaudited Financial Results For The Quarter End 30Th June 2019
Standalone Unaudited Financial Results for the quarter end 30th June 2019 Nath Bio-Genes (India) Ltd - 537291 - Outcome of Board Meeting
Outcome of Board Meeting held on 05th August 2019 Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation on Conference Call on 06th August 2019 Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashu Farms LLP Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for Board Meeting To Consider And Approve Unaudited Financial Results For The Quarter Ended 30Th June 2019
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2019 ,inter alia, to consider and approve Board Meeting to Consider and Approve Unaudited Financial Results for the quarter ended 30th June 2019